Disruptive AI & Physics for Antibody Design
8:30 am - Wednesday 26th August 2026
- Digital antibody design is advancing rapidly, and we will highlight the momentum building across the biotech industry over the past 20 years
- We draw lessons from the more mature field of computational small-molecule design and suggest that hybrid AI and physics-based workflows offer a promising path toward robust, transferable antibody design
- Real progress will depend on rigorous experimental validation of structure, function, developability and generalizability
